1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Apremilast
Trade Name:
Otezla
Manufacturer/Distributor:
Celgene Inc
www.celgenecanada.net
1-877-923-5436
Classification:
Immunosuppressant agent
ATC Class:
L04AA - selective immunosuppressant
Status:
active
Notice of Compliance (yyyy/mm/dd):
2014/11/12
Date Marketed in Canada (yyyy/mm/dd):
2014/12/08
Presentation:
Tablet: 10 mg. DIN: 02434318
Tablet: 30 mg. DIN: 02434334
Comments:
Apremilast is indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.
Limitations of use: it has not been studied and is therefore not indicated in combination with other systemic (conventional or biologic) therapies or phototherapy for psoriasis.
Back to:
Drug Product Listings 
